MedPath

PAEAN Biotechnology, Inc.

🇰🇷South Korea
Ownership
Holding
Established
2013-01-01
Employees
11
Market Cap
-
Website
http://www.paeanbio.com

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

Phase 1
Completed
Conditions
Polymyositis
Dermatomyositis
Interventions
Biological: PN-101
First Posted Date
2021-07-26
Last Posted Date
2024-04-03
Lead Sponsor
Paean Biotechnology Inc.
Target Recruit Count
9
Registration Number
NCT04976140
Locations
🇰🇷

Hanyang University Seoul Hospital, Seoul, Korea, Republic of

🇰🇷

Soonchunhyang University Seoul Hospital, Seoul, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath